Literature DB >> 10562482

Plasma N-terminal pro-brain natriuretic peptide and the ECG in the assessment of left-ventricular systolic dysfunction in a high risk population.

S Talwar1, I B Squire, J E Davies, D B Barnett, L L Ng.   

Abstract

AIMS: To examine the value of N-terminal pro-brain natriuretic peptide, abnormal electrocardiogram and other baseline clinical and laboratory variables in identifying patients with left ventricular systolic dysfunction in a high risk population. METHODS AND
RESULTS: We studied 243 patients (129 male, median age 73 years, range 20-94) referred for echocardiography. The relationship between left ventricular wall motion index and log N-terminal pro-brain natriuretic peptide, log creatinine, electrocardiogram, age, history of hypertension, history of ischaemic heart disease, gender, valvular disease and current drug therapy was examined using regression analysis. There was a strong correlation between N-terminal pro-brain natriuretic peptide and left ventricular wall motion index for the whole population (r=-0.624, P<0.001) and in those receiving diuretic +/- angiotensin converting enzyme inhibitor (r= -0.661, P<0.005) and in those receiving neither (r=-0.584, P<0. 005). On multiple regression analysis, log N-terminal pro-brain natriuretic peptide (P<0.001), age (P=0.015), current diuretic (P=0. 002) or angiotensin converting enzyme inhibitor use (P=0.001) and male gender (P=0.026) were independently associated with a low left ventricular wall motion index. Log N-terminal pro-brain natriuretic peptide alone (R(2)=39%) was a better predictor of left ventricular wall motion index than any other single or combination of factors. Plasma N-terminal pro-brain natriuretic peptide>275 pmol l(-1)predicted left ventricular wall motion index < or =1.2 with a sensitivity of 93.8%, a specificity of 55% and a negative predictive value of 93%. Left ventricular function was impaired in 18/36 patients with a normal electrocardiogram, in all of whom N-terminal pro-brain natriuretic peptide was >275 fmol ml(-1).
CONCLUSION: Of the variables studies, N-terminal pro-brain natriuretic peptide had the strongest correlation with reduced left ventricular wall motion index. The electrocardiogram had a poor predictive value for left ventricular systolic dysfunction in this population. Plasma N-terminal pro-brain natriuretic peptide can usefully predict patients with a reduced left ventricular wall motion index in whom echocardiographic examination may be appropriate. Copyright 1999 The European Society of Cardiology.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10562482     DOI: 10.1053/euhj.1999.1694

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  13 in total

Review 1.  Towards a blood test for heart failure: the potential use of circulating natriuretic peptides.

Authors:  S Talwar; P F Downie; L L Ng; I B Squire
Journal:  Br J Clin Pharmacol       Date:  2000-07       Impact factor: 4.335

2.  Analysis of the severity and prognosis assessment of aged patients with community-acquired pneumonia: a retrospective study.

Authors:  Kun Xiao; Long-Xiang Su; Bing-Chao Han; Peng Yan; Na Yuan; Jie Deng; Jia Li; Li-Xin Xie
Journal:  J Thorac Dis       Date:  2013-10       Impact factor: 2.895

3.  Plasma N terminal pro-brain natriuretic peptide and cardiotrophin 1 are raised in unstable angina.

Authors:  S Talwar; I B Squire; P F Downie; J E Davies; L L Ng
Journal:  Heart       Date:  2000-10       Impact factor: 5.994

4.  Diagnostic utility of specific electrocardiographical parameters in predicting left ventricular function.

Authors:  Altug Cincin; Beste Ozben; Okan Erdogan
Journal:  Exp Clin Cardiol       Date:  2012

5.  Increased brain and atrial natriuretic peptides in patients with chronic right ventricular pressure overload: correlation between plasma neurohormones and right ventricular dysfunction.

Authors:  I I Tulevski; M Groenink; E E van Der Wall; D J van Veldhuisen; F Boomsma; J Stoker; A Hirsch; J S Lemkes; B J Mulder
Journal:  Heart       Date:  2001-07       Impact factor: 5.994

Review 6.  Natriuretic peptides in heart valve disease.

Authors:  S G Ray
Journal:  Heart       Date:  2005-10-26       Impact factor: 5.994

7.  N-terminal pro B type natriuretic peptide, but not the new putative cardiac hormone relaxin, predicts prognosis in patients with chronic heart failure.

Authors:  C Fisher; C Berry; L Blue; J J Morton; J McMurray
Journal:  Heart       Date:  2003-08       Impact factor: 5.994

8.  Variability of NT-proBNP plasma and urine levels in patients with stable heart failure: a 2-year follow-up study.

Authors:  Raquel Cortés; Miguel Rivera; Antonio Salvador; Vicente Bertomeu; Fernando García de Burgos; Esther Roselló-Lletí; Manuel Portolés; Rafael Payá; Luis Martínez-Dolz; Vicente Climent
Journal:  Heart       Date:  2007-05-08       Impact factor: 5.994

9.  ECG determinants in adult patients with chronic right ventricular pressure overload caused by congenital heart disease: relation with plasma neurohormones and MRI parameters.

Authors:  J G J Neffke; I I Tulevski; E E van der Wall; A A M Wilde; D J van Veldhuisen; A Dodge-Khatami; B J M Mulder
Journal:  Heart       Date:  2002-09       Impact factor: 5.994

10.  NT-proBNP: a new diagnostic screening tool to differentiate between patients with normal and reduced left ventricular systolic function.

Authors:  M Bay; V Kirk; J Parner; C Hassager; H Nielsen; K Krogsgaard; J Trawinski; S Boesgaard; J Aldershvile
Journal:  Heart       Date:  2003-02       Impact factor: 5.994

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.